personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
In this issue, Upfront covers resilient supply chains, vaccine wars, and a gene therapy showing remarkable results in paralyzed animals. The focus of our cover feature is COVID-19; we gather experts from different sectors of the pharma industry to discuss how the pandemic has affected leadership and communication. Also in this issue: Ewoud van Tricht discusses analytical methods for vaccines, Alice Dunbabin talks about the benefits of biocatalysts; and Angela Myers and Michael Lehmicke explain how to standardize advanced therapy manufacture. We also have an interview with Sandy Macrae, CEO of Sangamo.